No Data
Express News | Jefferies Reinstates Buy on Viatris, Announces $15 Price Target
Viatris Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 07/19/2024 27.44% Jefferies → $15 Reinstates Buy → Buy 03/28/2024 10.45% Piper Sandler $11 → $13
Jefferies Maintains Viatris(VTRS.US) With Buy Rating, Maintains Target Price $15
Jefferies analyst Glen Santangelo maintains $Viatris(VTRS.US)$ with a buy rating, and maintains the target price at $15.According to TipRanks data, the analyst has a success rate of 49.5% and a
Big Pharma Rally After J&J Earnings
3 Generic Drug Stocks to Watch Amid Improving Market Prospects
BofA Securities Maintains Viatris(VTRS.US) With Sell Rating
BofA Securities analyst Jason Gerberry maintains $Viatris(VTRS.US)$ with a sell rating.According to TipRanks data, the analyst has a success rate of 44.4% and a total average return of -0.6% over
Ape Power :
KEN GRIFFIN COMMITTED FRAUD LIVE ON AIR!
- AMC Stock Short Squeeze Update